Summary by Moomoo AI
As of November 30, 2024, Trifolium Biosciences' legal and registered share capital remained unchanged, totaling $200,000. The number of issued shares also remained at 1,297,057,929 shares, with no increase or decrease. In the first public offering before and after the stock option plan adopted by the company in 2021, the number of share options slightly decreased, with 1,500 and 63,760 shares expiring respectively, but it did not affect the number of issued shares. Within this month, Trifolium Biosciences did not transfer or sell any treasury shares, and all related actions have been authorized by the board of directors and comply with listing rules. The company confirms that all legal and regulatory requirements have been met, and there have been no new issuances of shares or changes in treasury shares.
